Thursday, April 27, 2017
Company News: Page (1) of 1 - 04/21/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2017-2022 - Research and Markets

(April 21, 2017)

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2017-2022" report to their offering.

The report entitled Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2017-2022 represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil.

According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years. The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market during the next five years.

This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.

Key Topics Covered:

1 Preface

2 Research Methodology and Market Definitions

3 Executive Summary

4 Brazil Generic Drug Market - Introduction

5 Why is the Brazil Generic Drug Market So Lucrative

6 Global Generic Drug Market

7 Brazil Generic Drug Market

8 SWOT Analysis

9 Value Chain Analysis

10 Pricing Mechanism and Profit Margins at Various Levels of Supply Chain

11 Porter's Five Forces Analysis

12 Brazil Generic Drug Market: Competitive Landscape

13 Government Policy

14 Brazil Generic Drug Market: Key Success Factors

15 Brazil Generic Drug Market: Road Blocks

16 Generic Drug Manufacturing Process

17 Brazil Generic Drug Market: Key Company Profiles

Companies Mentioned

  • Ache Laboratories
  • EMS S.A.
  • Eurofarma Laboratórios S.A.
  • Hypermarcas S.A.
  • Sandoz
  • Sanofi Group
  • União Química Farmacêutica Nacional S.A

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Generic Drugs

Page: 1

Related Keywords:
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines